StockTipsArenaBeta

BUY Aurobindo Pharma — Chandan Taparia, Motilal Oswal

BUYAurobindo Pharma

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))1 Sept 2026via LiveMint Buy-or-Sell (topic)

Entry₹1,665Stated
Target₹1,820
Total upside +9.31%
Stop lossNot given
CMP₹1,66013h ago
Active-0.30%+9.64%upside left 7d left
Follow Chandan Taparia for new calls(35% target hit, 163 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 1 other Swing call on AUROPHARMASee 116 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 5:48 am IST
6 supporting3 neutral4 opposing
Supports the BUY call (6)

Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTD

NewsEt-Markets·31 Aug · 1w ago

(opens in new tab)

Aurobindo Pharma's subsidiary, Lannett Company LLC, has launched a generic version of Advair Diskus® in the US. This product is used to treat asthma and COPD.

NSE · Press Release·31 Aug · 1w ago

(opens in new tab)

Aurobindo Pharma's subsidiary, Lannett Company LLC, has launched a generic version of Advair Diskus in the US. This marks the first product from Aurobindo's inhalation pipeline to be commercialized in

BSE · Company Update·31 Aug · 1w ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·31 Aug · 1w ago

Aurobindo Pharma Share Price Gains As USFDA Concludes Inspection At Subsidiary Lannett's Unit

NewsNdtv-Profit·24 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (3)

Aurobindo Pharma Ltd's wholly owned subsidiary, Apitoria Pharma Private Limited, has incorporated a new wholly owned subsidiary named Ávogent Lifesciences Private Limited.

BSE · Company Update·1 Sept · 6d ago

(opens in new tab)

Aurobindo Pharma’s API plant gets three US FDA observations after inspection

NewsCnbc-Tv18·28 Aug · 1w ago

(opens in new tab)

Here's why these four pharma stocks are in focus today

NewsCnbc-Tv18·24 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (4)

MACD below its signal line — bearish momentum

Technicals · macd·7 Sept · today

USFDA Issues Three Observations To Aurobindo Pharma Arm's Facility In Andhra

NewsNdtv-Profit·28 Aug · 1w ago

(opens in new tab)

Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDA

NewsLivemint·24 Aug · 2w ago

(opens in new tab)

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·6 Aug · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.